Email this article to a friend Printable Version FREE Email Newsletter
Pharmanex, a Nu Skin Enterprises (NYSE: NUS) company, announced today a study that found Tegreen
97(R) to provide blood sugar control, body fat burning properties and
weight-loss benefits in an experimental setting of Metabolic Syndrome X
subjects -- a precursor to type-2 diabetes. The findings of the new study
were recently presented at the American Heart Association's Sixth Annual
Conference in Washington, D.C.
"We are honored by the American Heart Association's invitation to present
our newest findings on Tegreen 97," said Joe Chang, Ph.D., president of
Pharmanex. "The results of this study are very meaningful in building a
greater body of knowledge related to two significant health issues today:
weight gain and lack of blood sugar control. We have shown with this and
other studies that Tegreen 97 can have a significant beneficial effect in
managing these two health conditions."
Tegreen 97(R) is a proprietary, decaffeinated green tea extract
standardized to 97 percent polyphenols -- two-thirds of which are catechins,
the element responsible for the observed effect. Each capsule of Tegreen
97(R) contains the same amount of catechins as seven cups of the traditionally
brewed green tea drink.
About the Study
The purpose of this study was to examine the effects of Tegreen 97(R) in
enhancing insulin sensitivity and improving glucose-lipid metabolism. In
addition, the research examined the effects of the proprietary green tea
supplement in lowering body weight and weight of abdominal fat and inhibiting
angiogenesis, which is the formation and differentiation of blood vessels, a
key pathological process in the development of abnormal cells. Angiogenesis
is hypothesized to play an important role in development of obesity. Following
are the results of the study:
• Tegreen 97(R) enhanced insulin sensitivity
• Improved glucose-lipid metabolism
• Increased fat burning and decreased body fat percentage
• Lowered body weight associated with inhibited angiogenesis.
"Our findings proved that in addition to its significance in protecting
cells from abnormal mutation, inhibition of angiogenesis by Tegreen 97 is
associated with reduction of body weight," said Josh Zhu, senior director of
clinical R&D for Pharmanex and chief researcher of the study. "Tegreen 97 not
only supports the general belief in the anti-aging benefits of tea catechins
but may also provide benefits to people with Metabolic Syndrome X, overweight
and those with subsequent cardiovascular and brain health concerns."
Tegreen 97(R) is also included in LifePak(R), the company's comprehensive
multivitamin/mineral and antioxidant supplement.
Pharmanex
Pharmanex, a Nu Skin Enterprises company, applies pharmaceutical processes
and scientific measurement to create nutritional supplements for more than
40 markets worldwide. Pharmanex(R) products are sold direct to the consumer
through the Internet and a network of independent distributors. For more
information, go to http://www.pharmanex.com.
The Company
Get articles like this delivered to you FREE in our popular email newsletter
|

(FREE) Thursday evening, Feb. 11 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with our special guest John Roulac, Founder of Nutiva. This special show "Superfood Nutrition: Discover the NEWest Trends" will reveal delicious ways to enjoy life. Register via email to receive call-in details:
|
|
 Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free! Visit NaturalPedia.com.
|
NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
|
|